Doehn, C.; Bögemann, M.; Grünwald, V.; Welslau, M.; Bedke, J.; Schostak, M.; Wolf, T.; Ehneß, R.; Degenkolbe, E.; Witecy, S.;
et al. The Non-Interventional PAZOREAL Study to Assess the Effectiveness and Safety of Pazopanib in a Real-Life Setting: Reflecting a Changing mRCC Treatment Landscape. Cancers 2022, 14, 5486.
https://doi.org/10.3390/cancers14225486
AMA Style
Doehn C, Bögemann M, Grünwald V, Welslau M, Bedke J, Schostak M, Wolf T, Ehneß R, Degenkolbe E, Witecy S,
et al. The Non-Interventional PAZOREAL Study to Assess the Effectiveness and Safety of Pazopanib in a Real-Life Setting: Reflecting a Changing mRCC Treatment Landscape. Cancers. 2022; 14(22):5486.
https://doi.org/10.3390/cancers14225486
Chicago/Turabian Style
Doehn, Christian, Martin Bögemann, Viktor Grünwald, Manfred Welslau, Jens Bedke, Martin Schostak, Thomas Wolf, Rainer Ehneß, Elisa Degenkolbe, Stefanie Witecy,
and et al. 2022. "The Non-Interventional PAZOREAL Study to Assess the Effectiveness and Safety of Pazopanib in a Real-Life Setting: Reflecting a Changing mRCC Treatment Landscape" Cancers 14, no. 22: 5486.
https://doi.org/10.3390/cancers14225486
APA Style
Doehn, C., Bögemann, M., Grünwald, V., Welslau, M., Bedke, J., Schostak, M., Wolf, T., Ehneß, R., Degenkolbe, E., Witecy, S., & Goebell, P. J.
(2022). The Non-Interventional PAZOREAL Study to Assess the Effectiveness and Safety of Pazopanib in a Real-Life Setting: Reflecting a Changing mRCC Treatment Landscape. Cancers, 14(22), 5486.
https://doi.org/10.3390/cancers14225486